Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries.

Xanthine dehydrogenase/oxidase blockade might reduce risk of neurodegenerative disease. However, further research will be necessary to confirm that the associations related to this pathway are causal or to examine whether this mechanism slows progression.